Adagio Therapeutics (ADGI) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…

Adagio Therapeutics (ADGI) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: March 19, 2025 (11:29)

Sector: Healthcare

The share price of Adagio Therapeutics, Inc. (ADGI) now

This company is DELISTED
Latest session on the 19th of March for
Adagio Therapeutics, Inc. is negative
Trading Volume:
Open: 0 /  High: 0 /  Low: 0

Are you interested in Adagio Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Adagio Therapeutics stock price in 2025, 2026, 2027. How much will one Adagio Therapeutics share be worth in 2025 - 2027?

When should I take profit in Adagio Therapeutics stock? When should I record a loss on Adagio Therapeutics stock? What are analysts' forecasts for Adagio Therapeutics stock? What is the future of Adagio Therapeutics stock? We forecast Adagio Therapeutics stock performance using neural networks based on historical data on Adagio Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Adagio Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Adagio Therapeutics shares. This happens once a day.


Historical and forecast chart of Adagio Therapeutics stock

The chart below shows the historical price of Adagio Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Adagio Therapeutics stock price can be found in the table below.

No data

Long-term forecasts by years.

Adagio Therapeutics, Inc., a clinical biopharmaceutical company, is engaged in the discovery, development and commercialization of antibody-based solutions for the treatment of infectious diseases in the United States. Its main product candidate is ADG20, a neutralizing antibody undergoing phase II / III clinical trials for the treatment and prevention of coronavirus disease. The company has entered into a collaboration agreement with Adimab, LLC in the area of proprietary antibody detection and optimization. Adagio Therapeutics, Inc.

Trending Themes in the Healthcare Sector

Adagio Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 21 4.67 4.61 4.73 2.63
Mar 22 4.66 4.61 4.72 2.38
Mar 23 4.68 4.63 4.81 3.84
Mar 24 4.71 4.63 4.78 3.13
Mar 25 4.68 4.54 4.81 5.94
Mar 26 4.86 4.72 4.99 5.56
Mar 27 4.78 4.70 4.93 4.79
Mar 28 4.76 4.72 4.80 1.61
Mar 29 4.80 4.68 4.86 3.73
Mar 30 4.83 4.75 4.96 4.39
Mar 31 4.89 4.85 4.93 1.78
Apr 01 4.97 4.92 5.11 3.84
Apr 02 4.93 4.88 4.99 2.18
Apr 03 4.87 4.82 4.94 2.46
Apr 04 4.85 4.79 4.97 3.77
Apr 05 4.93 4.79 5.04 5.23
Apr 06 4.99 4.92 5.11 3.82
Apr 07 4.97 4.82 5.13 6.36
Apr 08 4.94 4.88 5.04 3.32
Apr 09 4.93 4.86 5.02 3.25
Apr 10 4.90 4.85 5.00 2.91
Apr 11 4.86 4.76 4.95 3.79
Apr 12 4.77 4.63 4.87 5.14
Apr 13 4.79 4.75 4.83 1.65
Apr 14 4.96 4.89 5.03 2.76
Apr 15 5.08 5.01 5.19 3.57
Apr 16 4.97 4.82 5.02 4.04
Apr 17 4.92 4.83 4.97 2.90
Apr 18 5.00 4.95 5.07 2.34
Apr 19 4.93 4.84 5.03 3.96

Adagio Therapeutics Daily Price Targets


Adagio Therapeutics Stock Forecast 03-21-2025.

Forecast target price for 03-21-2025: $4.67.
Positive dynamics for Adagio Therapeutics shares will prevail with possible volatility of 2.567%.
Pessimistic target level: 4.61
Optimistic target level: 4.73

Adagio Therapeutics Stock Forecast 03-22-2025.

Forecast target price for 03-22-2025: $4.66.
Negative dynamics for Adagio Therapeutics shares will prevail with possible volatility of 2.327%.
Pessimistic target level: 4.61
Optimistic target level: 4.72

Adagio Therapeutics Stock Forecast 03-23-2025.

Forecast target price for 03-23-2025: $4.68.
Positive dynamics for Adagio Therapeutics shares will prevail with possible volatility of 3.702%.
Pessimistic target level: 4.63
Optimistic target level: 4.81

Adagio Therapeutics Stock Forecast 03-24-2025.

Forecast target price for 03-24-2025: $4.71.
Positive dynamics for Adagio Therapeutics shares will prevail with possible volatility of 3.039%.
Pessimistic target level: 4.63
Optimistic target level: 4.78

Adagio Therapeutics Stock Forecast 03-25-2025.

Forecast target price for 03-25-2025: $4.68.
Negative dynamics for Adagio Therapeutics shares will prevail with possible volatility of 5.605%.
Pessimistic target level: 4.54
Optimistic target level: 4.81

Adagio Therapeutics Stock Forecast 03-26-2025.

Forecast target price for 03-26-2025: $4.86.
Positive dynamics for Adagio Therapeutics shares will prevail with possible volatility of 5.263%.
Pessimistic target level: 4.72
Optimistic target level: 4.99

ADGI (ADGI) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Apr. 4.26 2.93 4.67 37.31
May. 5.79 5.29 6.44 17.87
Jun. 5.16 3.87 5.64 31.38
Jul. 6.06 5.02 7.24 30.68
Aug. 3.77 3.40 4.16 18.35
Sep. 3.56 2.90 4.37 33.71
Oct. 3.95 3.44 4.46 22.81
Nov. 3.98 2.94 4.79 38.59
Dec. 3.22 2.78 4.19 33.59

Adagio Therapeutics forecast for this year


Adagio Therapeutics Stock Prediction for Apr 2025

An downtrend is forecast for this month with an optimal target price of $4.25914. Pessimistic: $2.93. Optimistic: $4.67


Adagio Therapeutics Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $5.78732. Pessimistic: $5.29. Optimistic: $6.44


Adagio Therapeutics Stock Prediction for Jun 2025

An downtrend is forecast for this month with an optimal target price of $5.15534. Pessimistic: $3.87. Optimistic: $5.64


Adagio Therapeutics Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $6.06011. Pessimistic: $5.02. Optimistic: $7.24


Adagio Therapeutics Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $3.76757. Pessimistic: $3.40. Optimistic: $4.16


Adagio Therapeutics Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $3.56186. Pessimistic: $2.90. Optimistic: $4.37


Adagio Therapeutics Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $3.95081. Pessimistic: $3.44. Optimistic: $4.46


Adagio Therapeutics Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $3.98163. Pessimistic: $2.94. Optimistic: $4.79


Adagio Therapeutics Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $3.22074. Pessimistic: $2.78. Optimistic: $4.19



Adagio Therapeutics (ADGI) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.88 2.24 3.33 32.72
Feb 1.98 1.42 2.37 40.14
Mar 2.14 1.50 2.55 41.26
Apr 1.74 1.32 2.27 41.69
May 1.42 1.06 1.70 37.86
Jun 1.37 1.01 1.62 37.57
Jul 1.61 1.12 1.76 36.51
Aug 1.73 1.40 2.04 31.52
Sep 1.62 1.32 1.78 26.20
Oct 1.51 1.31 1.93 32.07
Nov 1.43 1.28 1.60 20.25
Dec 1.48 1.03 1.64 36.83

Adagio Therapeutics (ADGI) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 1.39 1.19 1.68 29.41
Feb 1.21 1.07 1.51 29.12
Mar 1.62 1.42 1.96 27.38
Apr 1.77 1.45 2.08 30.19
May 2.06 1.76 2.50 29.54
Jun 2.06 1.76 2.39 26.23
Jul 1.49 1.30 1.66 21.72
Aug 1.39 1.27 1.53 17.29
Sep 1.38 1.17 1.55 24.27
Oct 1.63 1.41 1.78 20.68
Nov 2.01 1.44 2.58 44.32
Dec 2.57 1.78 3.35 46.79

Adagio Therapeutics information and performance

Adagio Therapeutics Address

N/A

Market Capitalization: N/A $

Market capitalization of the Adagio Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ADGI shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Adagio Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Adagio Therapeutics Stock)

Should I Buy Adagio Therapeutics Shares in 2025 year?

The maximum forecasted share price for next year is $2.88, Это на 1.72$ меньше чем текущая цена акций. Инвестируя сегодня в акции Adagio Therapeutics на срок 1 год вы получите убыток в размере 37.36%. With an investment horizon of up to two years, the target share price is 2.57$. Убыток: 44.06% (-2.03$ на каждую акцию).

Does Adagio Therapeutics pay dividends?

No, it does not

Which economic sector do Adagio Therapeutics's shares belong to?

Adagio Therapeutics's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Adagio Therapeutics's shares?

You can view all the stocks that are part of the same sector as Adagio Therapeutics's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.